Ocular Surface Disease as an Immune-related Adverse Event of Immune Checkpoint Inhibitor Therapy.

چکیده

Ocular surface disease, encompassing scleritis, episcleritis, keratitis, and sicca syndrome, is an increasingly recognized immune-related adverse event of immune checkpoint inhibitors (ICIs), yet its pharmacovigilance profile has not been systematically characterized across all approved ICI…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط

• یووئیت و التهاب داخل چشمی
• عفونت های چشمی